Cell line · CVCL_0317
HT-1080
Cancer cell line, Homo sapiens. Fibrosarcoma. 111 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. HT-1080. Cell lines, record CVCL_0317. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0317
On this page
Cell line
As Cellosaurus gives it.
- Name
- HT-1080
- Accession
- CVCL_0317
- RRID
- RRID:CVCL_0317
- Synonyms
- Ht-1080, HT 1080, HT1080, HT 1080.T
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 35Y
- Category
- Cancer cell line
- Diseases
- Fibrosarcoma (NCIt C3043); Fibrosarcoma (ORDO Orphanet_2030)
- Derived from
- Bone, pelvis, acetabulum (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Caution | This cell line is considered by some researchers to represent a dedifferentiated chondrosarcoma due to the presence of an IDH1 mutation (PubMed=26368816). |
Source Cellosaurus
Papers111
2 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Targeting GPX4 and FSP1 to exploit ferroptotic vulnerability in Ewing sarcoma. | Front Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A guide to selecting high-performing antibodies for Netrin-1 (UniProt ID: O95631) for use in western blot and immunoprecipitation. | F1000Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| An ancient alpharetrovirus lineage in bats: Evolutionary insights and possible roles in reproduction. | PLoS Genet | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Model-dependent GD2 upregulation in Ewing sarcoma with the EZH2 inhibitor tazemetostat: Prerequisites for combination with GD2-specific CAR T cells. | Res Sq | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Systematic Targeting of Protein Complexes with Molecular COUPLrs. | Cancer Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Covalent Inhibition of SHMT2 by Gambogic Acid Induces Ferroptosis Through Mitochondrial Collapse in Triple-Negative Breast Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| p300 Degradation by the p53-SIAH1 Axis Relieves TBK1 Acetylation to Enhance Innate Antiviral Immunity. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MORC3 represses a tandem repeat enhancer to regulate interferon. | EMBO J | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MiR-940 Suppresses Ferroptosis by Controlling Expression of Key Regulatory Genes. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Drug Screening of Sarcoma Cells: Finding Shared Sensitivities. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 111
See all 111 papersRelatives62
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | 2C4 [Human fibrosarcoma] | CVCL_1D50 | Cell lines | |
| Derived from it | 2fTGH | CVCL_0115 | Cell lines | |
| Derived from it | EDITGENE HT-1080-CopGFP | CVCL_F6A3 | Cell lines | |
| Derived from it | EDITGENE HT-1080-FLUC | CVCL_F5SL | Cell lines | |
| Derived from it | EDITGENE ht1080-Cas9 | CVCL_F5PY | Cell lines | |
| Derived from it | FLYA13 | CVCL_8870 | Cell lines | |
| Derived from it | FLYRD18 | CVCL_8871 | Cell lines | |
| Derived from it | HL116 | CVCL_RW47 | Cell lines | |
| Derived from it | HP | CVCL_3715 | Cell lines | |
| Derived from it | HT-1080 JH-1/FIX | CVCL_XG90 | Cell lines |
1 to 10 of 62
See all 62 relativesCell banks20
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ABM | T8971 | ABM | |
| ATCC | CCL-121 | ATCC | |
| ATCC | CRL-7951 | Discontinued | Cellosaurus |
| BCRC | 60037 | BCRC | |
| BCRJ | 0110 | BCRJ | |
| CCTCC | GDC0105 | Cellosaurus | |
| CLS | 300216 | CLS | |
| DSMZ | ACC-315 | DSMZ | |
| ECACC | 85111505 | ECACC | |
| EDITGENE | EDC00188 | EDITGENE |
1 to 10 of 20
See all 20 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0317
GET https://conductscience.org/api/cell-lines/v1/CVCL_0317/papers?page=2